Don't Use Delafloxacin to Treat Most Skin Infections
Delafloxacin (Baxdela, baks-DEH-lah) is a new quinolone antibiotic.
Think of it as similar to levofloxacin, but so far it's only approved to treat skin infections.
And lab data suggest delafloxacin may have better methicillin-resistant Staph aureus (MRSA) coverage than other quinolones.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote